Public Announcement From Lotus Pharmaceuticals, Inc.
BEIJING, April 10, 2012 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTCBB: LTUS) ("Lotus" or the "Company") issued the following statement: For the past five years when Lotus Pharmaceuticals became a public company on the OTC bulletin board, the Company invested a significant amount of capital...
Lotus Pharmaceuticals Announces Third Quarter 2011 Financial Results
BEIJING, Nov. 11, 2011 /PRNewswire-Asia-FirstCall/ -- *Lotus Pharmaceuticals, Inc.* (OTCBB: LTUS) ("Lotus" or the "Company"), a profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China ("PRC"), today announced its financial results for the third fiscal qu...
Lotus Pharmaceuticals Announces Second Quarter Fiscal 2011 Financial Results
BEIJING, Aug. 15, 2011 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTCBB: LTUS) ("Lotus" or the "Company"), a profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China ("PRC"), today announced its financial results for the quarter ended Jun...
Lotus Pharmaceuticals Announces First Quarter Fiscal 2011 Financial Results
BEIJING, May 16, 2011 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTCBB: LTUS) ("Lotus" or the "Company"), a profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China ("PRC"), today announced its financial results for the first quarter ende...
Lotus Pharmaceuticals Responds to Investor Concerns in Exclusive Interview
BEIJING, April 25, 2011 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTCBB: LTUS) ("Lotus" or the "Company"), a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China ("PRC"), announced today that its Vice President of Corpo...
Lotus Pharmaceuticals Announces Fiscal 2010 Financial Results
Lotus Pharmaceuticals Announces Fiscal 2010 Financial Results BEIJING, March 29, 2011 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People...
Lotus Pharmaceuticals to Expand Construction of Beijing Facility
Construction Remains on Schedule for June 2011 Completion BEIJING, Feb. 4, 2011 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Repub...
Lotus Pharmaceuticals Provides Inner Mongolia Land Price Guidance from Cha You Qian Qi Government
BEIJING, Jan. 27, 2011 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUSD) ("Lotus" or the "Company"), a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China ("PRC"), announced today that in response to recent in...
Lotus Pharmaceuticals Announces Approval of Reverse Stock Split
2-for-1 Reverse Split Effected in Connection with National Exchange Listing Application BEIJING, Dec. 31, 2010 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a fast-growing, profitable developer, manufacturer and seller of medicin...
Lotus Pharmaceuticals Announces Change of Directors
Strategic Move Intended to Strengthen Management Team Ahead of National Exchange Listing Application BEIJING, Dec. 21, 2010 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a fast-growing, profitable developer, manufacturer and seller of medici...
Lotus Pharmaceuticals Signs New Distribution Contracts at PHARMCHINA Conference
BEIJING, Dec. 15, 2010 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China ("PRC"), announced today that it signed contr...
Lotus Pharmaceuticals Announces Update on Land in Inner Mongolia
Company to Sell or Transfer Land Parcel to Focus on Core Business BEIJING, Dec. 9, 2010 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People...
Lotus Pharmaceuticals Announces Participation in PHARMCHINA's 64th National Drug Fair Conference
BEIJING, Dec. 9, 2010 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China ("PRC"), announced today that it will particip...
Lotus Pharmaceuticals Announces Third Quarter 2010 Financial Results
-- 3Q Revenues up 27.5% YoY to $18.5M -- 3Q Net Income up 24.3% YoY to $6.7M; EPS $0.12 -- Company reaffirms previous guidance of $73.6M in revenues and $21.4M in net income BEIJING, Nov. 11, 2010 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the...
Lotus Pharmaceuticals Announces Conference Call to Discuss Third Quarter 2010 Financial Results
BEIJING, Nov. 10, 2010 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China ("PRC"), announced today that it will hold a conference...
Lotus Pharmaceuticals Receives SFDA Approval to Initiate Phase I Clinical Trials of Asthma Drug R-Bambuterol
BEIJING, Oct. 27 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China ("PRC"), announced today that it received approval ...
Lotus Pharmaceuticals Preparing to Apply for National Exchange Listing
- Company Strengthening Its Board of Directors BEIJING, Oct. 23 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS( http://studio-5.financialcontent.com/prnews?Page=Quote&Ticker=LTUS )) ("Lotus" or the "Company"), a fast-growing, profitable developer, manufacture...
Lotus Pharmaceuticals Announces New Patent for Controlled-Release Diabetes Drug
- Company expects controlled-release gliclazide tablets to generate $15 million in annual revenues BEIJING, Oct. 19 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a fast-growing, profitable developer, manufacturer and seller of me...
Lotus Pharmaceuticals Retains Sichenzia Ross Friedman Ference LLP as General Legal Counsel
BEIJING, Oct. 6 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China ("PRC"), announced today that the Company has retain...
Lotus Pharmaceuticals Announces Two Senior Management Appointments
BEIJING, Sept. 23 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China ("PRC"), announced today that the Company has appointed Mr. ...
